Analysis of PALB2/FANCN-associated breast cancer families

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 16, 2007, Pages 6788-6793

  Tischkowitz, Marc ^a,b   Xia, Bing ^d   Sabbaghian, Nelly ^a,b   Reis Filho, Jorge S ^e   Hamel, Nancy ^a,f   Li, Guilan ^d   Van Beers, Erik H ^g   Li, Lili ^a,b   Khalil, Tayma ^a,b   Quenneville, Louise A ^c   Omeroglu, Atilla ^a   Poll, Aletta ^h   Lepage, Pierre ^a   Wong, Nora ^a,b   Nederlof, Petra M ^g   Ashworth, Alan ^e   Tonin, Patricia N ^a,f   Narod, Steven A ^h   Livingston, David M ^d   Foulkes, William D ^a,b,f  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g NETHERLANDS CANCER INSTITUTE   (Netherlands)

^h WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

DNA repair; FANCN; Fanconi anemia; Hereditary predisposition

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 18Q; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPAIR; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PALB2 GENE; PRIORITY JOURNAL; SCORING SYSTEM; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; AGED; BLOOD; BREAST TUMOR; FANCONI ANEMIA; FRAMESHIFT MUTATION; GENETICS; MALE; MELANOMA; MIDDLE AGED; PEDIGREE; POINT MUTATION;

NUCLEAR PROTEIN; PALB2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DNA MUTATIONAL ANALYSIS; FANCONI ANEMIA; FEMALE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NUCLEAR PROTEINS; PEDIGREE; POINT MUTATION; TUMOR SUPPRESSOR PROTEINS;

EID: 34249857115     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0701724104     Document Type: Article

References (25)

1. Wooster R, Weber BL (2003) N Engl J Med 348:2339-2347.
2. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM (2006) Mol Cell 22:719-729.
3. Patel KJ, Vu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR (1998) Mol Cell 1:347-357.
4. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, et al. (2007) Nat Genet 39:162-164.
5. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, et al. (2007) Nat Genet 39:159-161.
6. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, et al. (2007) Nat Genet 39:165-167.
7. Erkko H, Xia B, Nikkilä, J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen, SM, Rapakko K, et al. (2007) Nature 446:316-319.
8. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) J Clin Oncol 20:1480-1490.
9. Oros KK, Ghadirian P, Greenwood CM, Perret C, Shen Z, Paredes Y, Arcand SL, Mes-Masson AM, Narod SA, Foulkes WD, et al. (2004) Int J Cancer 112:411-419.
10. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, et al. (2002) Nat Genet 31:55-59.
11. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, Szabo C, Southey M, Renard H, et al. (2006) Genes Chromosomes Cancer 45:646-655.
12. Tirkkonen M, Kainu T, Loman N, Johannsson OT, Olsson H, Barkardottir RB, Kallioniemi OP, Borg A (1999) Genes Chromosomes Cancer 24:56-61.
13. van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, Cornelisse CJ, Verhoef S, Hogervorst FB, van't Veer LJ, Nederlof PM (2005) Cancer Res 65:822-827.
14. Miller BJ, Wang D, Krahe R, Wright FA (2003) Am J Hum Genet 73:748-767.
15. Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JR, Kerin MJ (2000) Int J Cancer 86:494-500.
16. Zudaire I, Odero MD, Caballero C, Valenti C, Martinez-Penuela JM, Isola J, Calasanz MJ (2002) Histopathology 40:547-555.
17. Delias A, Torhorst J, Schultheiss E, Mihatsch MJ, Moch H (2002) Clin Cancer Res 8:1210-1216.
18. Morikawa A, Williams TY, Dirix L, Colpaert C, Goodman M, Lyles RH, Zhong D, Zhou W (2005) Breast Cancer Res 7:R1051-R1057.
19. Parmigiani G, Berry D, Aguilar O (1998) Am J Hum Genet 62:145-158.
20. Berry DA, Iversen ES, Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, et al. (2002) J Clin Oncol 20:2701-2712.
21. Oros KK, Ghadirian P, Maugard CM, Perret C, Paredes Y, Mes-Masson AM, Foulkes WD, Provencher D, Tonin PN (2006) Clin Genet 70:320-329.
22. Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, et al. (2005) J Pathol 207:1-13.
23. van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FB, Verhoef S, Nederlof PM (2006) Br J Cancer 94:333-337.
24. Arriola E, Lambros MB, Jones C, Dexter T, Mackay A, Tan DS, Tamber N, Fenwick K, Ashworth A, Dowsett M, Reis-Filho JS (2007) Lab Invest 87:75-83.
25. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E (2004) Bioinformatics 20:3413-3422.